Nina Silberstein

Penn’s Giant Cell Arteritis Fast-Track Program Provides Rapid Evaluation

The tricky part of giant cell arteritis (GCA) is the need for rapid evaluation, given the high risk of rapid vision loss and the importance of getting appropriate diagnostic tests, such as a temporal artery biopsy, soon after starting treatment. Unfortunately, there are not a lot of outpatient programs that…...

Read more

The OHSU Vasculitis Center: Specializing in Multidisciplinary Care

The most common form of vasculitis in adults over the age of 50 is giant cell arteritis (GCA), an inflammation of the blood vessels that primarily affects the head—especially the temples and scalp—but also arteries in other parts of the body, including the aorta. Early diagnosis is critical in GCA…...

Read more

Dr. Stephanie Garner Named Recipient of 2020 VCRC-VF Fellowship Award

Stephanie Garner, MD, MSc, FRCPC, developed an interest in vasculitis as an internal medicine resident at the University of Calgary in Alberta, Canada, while admitting a patient to its nephrology service. The patient had pulmonary renal syndrome—respiratory failure that involves bleeding in the lungs and kidney failure—due to ANCA-associated vasculitis.…...

Read more

Rituximab Gains Expanded Approval in Pediatrics

  The Food and Drug Administration has expanded the approval of Rituxan® injection (rituximab) to include the treatment of children ≥2 years of age who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), in combination with glucocorticoids. Rituximab is a CD20-directed cytolytic monoclonal antibody first approved in 1997 to…...

Read more

Podcast Series Offers Insights on What It’s Like to Live with Vasculitis

  Although being diagnosed with vasculitis can feel scary at times, one thing that can help you manage the disease and come to terms with it is talking to other patients. VF Board Member Sara Baird Amodio, MSW, EdD, was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome)…...

Read more